Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
Gabay
Cem
C
Division of Rheumatology at University Hospitals of Geneva, Geneva, Switzerland. cem.gabay@hcuge.ch